thymopentin has been researched along with Colitis Gravis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Birnbaumer, L; Cao, Q; Gao, X; Hao, K; Li, X; Lin, Y; Liu, X; Lu, Y; Qin, D; Quan, F; Wang, Y; Yang, H; Yang, Y; Yue, C; Zhan, Y; Zhang, Z | 1 |
1 other study(ies) available for thymopentin and Colitis Gravis
Article | Year |
---|---|
Thymopentin ameliorates dextran sulfate sodium-induced colitis by triggering the production of IL-22 in both innate and adaptive lymphocytes.
Topics: Adaptive Immunity; Animals; Cell Line, Tumor; Colitis, Ulcerative; Colon; Dextran Sulfate; Disease Models, Animal; Feces; Gastrointestinal Microbiome; HCT116 Cells; Humans; Immunity, Innate; Interleukin-22; Interleukins; Intestinal Mucosa; Lymphocytes; Male; Mice; Mice, Inbred C57BL; Spleen; T-Lymphocytes, Regulatory; Thymopentin | 2019 |